These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 27582123
1. Clinical application of DEX/CRH test and multi-channel NIRS in patients with depression. Kinoshita S, Kanazawa T, Kikuyama H, Yoneda H. Behav Brain Funct; 2016 Aug 31; 12(1):25. PubMed ID: 27582123 [Abstract] [Full Text] [Related]
2. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M. Neuropsychopharmacology; 2006 Jan 31; 31(1):212-20. PubMed ID: 16123748 [Abstract] [Full Text] [Related]
3. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders. Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M. J Psychiatr Res; 2008 Oct 31; 42(14):1154-62. PubMed ID: 18281062 [Abstract] [Full Text] [Related]
4. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression. Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K. Psychoneuroendocrinology; 2008 Feb 31; 33(2):152-61. PubMed ID: 18068306 [Abstract] [Full Text] [Related]
5. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker? Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F. Biol Psychiatry; 2007 Jul 01; 62(1):47-54. PubMed ID: 17123470 [Abstract] [Full Text] [Related]
6. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S. Neuropsychopharmacology; 2003 Dec 01; 28(12):2169-78. PubMed ID: 12931142 [Abstract] [Full Text] [Related]
7. Relationships of DEX/CRH and GHRH test results to the outcome of depression--preliminary results suggest the GHRH test may predict relapse after discharge. Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K. J Psychiatr Res; 2008 Apr 01; 42(5):356-64. PubMed ID: 17412362 [Abstract] [Full Text] [Related]
8. Relationship between the prefrontal function and the severity of the emotional symptoms during a verbal fluency task in patients with major depressive disorder: a multi-channel NIRS study. Liu X, Sun G, Zhang X, Xu B, Shen C, Shi L, Ma X, Ren X, Feng K, Liu P. Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct 03; 54():114-21. PubMed ID: 24842802 [Abstract] [Full Text] [Related]
11. The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression. Veen G, Derijk RH, Giltay EJ, van Vliet IM, van Pelt J, Zitman FG. Eur Neuropsychopharmacol; 2009 Jun 03; 19(6):409-15. PubMed ID: 19327969 [Abstract] [Full Text] [Related]
12. Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode. Gervasoni N, Bertschy G, Osiek C, Perret G, Denis R, Golaz J, Rossier MF, Bondolfi G, Aubry JM. J Psychiatr Res; 2004 Jun 03; 38(6):553-7. PubMed ID: 15458850 [Abstract] [Full Text] [Related]
13. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder. de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H. Psychoneuroendocrinology; 2008 Apr 03; 33(3):313-20. PubMed ID: 18215470 [Abstract] [Full Text] [Related]
14. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F. Psychoneuroendocrinology; 2009 Jan 03; 34(1):99-109. PubMed ID: 18829172 [Abstract] [Full Text] [Related]
17. Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder. Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M. J Psychiatr Res; 2003 Jan 03; 37(2):135-43. PubMed ID: 12842167 [Abstract] [Full Text] [Related]
18. The dex/CRH test--is it better than the DST? Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH. Psychoneuroendocrinology; 2006 Aug 03; 31(7):889-94. PubMed ID: 16701957 [Abstract] [Full Text] [Related]
19. Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression. Bschor T, Adli M, Baethge C, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M. Neuropsychopharmacology; 2002 Sep 03; 27(3):470-8. PubMed ID: 12225704 [Abstract] [Full Text] [Related]
20. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression. Behnken A, Bellingrath S, Symanczik JP, Rieck MJ, Zavorotnyy M, Domschke K, Arolt V, Zwanzger P. Psychoneuroendocrinology; 2013 Mar 03; 38(3):447-54. PubMed ID: 22840287 [Abstract] [Full Text] [Related] Page: [Next] [New Search]